Summit Partners Public Asset Management, LLC Abb Vie Inc. Transaction History

Summit Partners Public Asset Management, LLC

  • $2.79 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$64.5 - $97.79 $8.39 Million - $12.7 Million
-130,074 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$72.13 - $90.25 $7.21 Million - $9.02 Million
-99,926 Reduced 43.45%
130,074 $11.5 Million
Q3 2019

Nov 14, 2019
BUY
$62.98 - $75.72 $14.5 Million - $17.4 Million
230,000 New
230,000 $17.4 Million

Others Institutions Holding ABBV

# of Institutions
3,855
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Summit Partners Public Asset Management, LLC Portfolio

Follow Summit Partners Public Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email